Amr Mohamed MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas (NCT05262556) | Amr Mohamed MD | 2022-12-15 |
Track Amr Mohamed MD automatically
Every clearance here is in the API, with alerts when new ones post.